Aneurysmal bone cysts (ABCs) were identified as a distinct condition in 1942. While their exact cause is unclear, recent studies suggest a potential neoplastic origin involving the USP6 gene. These rare, benign bone tumors typically affect children and adolescents, with the highest occurrence in the second decade of life. Although they can develop in any bone, ABCs are most commonly observed in the long bones of the limbs and the spine. Despite their non-cancerous nature, ABCs can lead to significant health issues due to their locally aggressive behavior, causing pain, swelling, deformity, and fractures. Timely diagnosis and appropriate treatment are essential to manage symptoms and prevent complications.
Epidemiology
Aneurysmal bone cysts (ABCs) are rare, benign bone tumors, comprising 1-2% of primary bone tumors. They often affect children and adolescents, with a peak incidence between ages 5 and 20. While occurring in any bone, they preferentially appear in long bone metaphyses, spine, pelvis, and extremities. Clinical presentation includes pain, swelling, and restricted joint movement, with fractures possible. Treatment involves surgical intervention with a recurrence risk of 10-30%, emphasizing the need for comprehensive understanding in diagnosis and management.
Anatomy
Pathophysiology
The development of aneurysmal bone cysts (ABCs) involves a multifaceted interaction of genetic, molecular, and environmental factors. Although the exact cause remains incompletely understood, various theories have been proposed to explain their mechanisms:
Vascular Disturbances: Initially proposed by Lichtenstein in 1950, this theory suggests that ABCs arise as reactive lesions triggered by regional vascular disruptions. These disturbances result in elevated intraosseous pressure, leading to bone destruction and expansion.
Traumatic Etiology: Another hypothesis implicates trauma as an initial trigger, followed by an abnormal reparative process. Trauma may disrupt the bone’s vascular supply, leading to the formation of a cystic cavity that undergoes subsequent expansion and remodeling.
Genetic Alterations: Recent studies have identified recurrent chromosomal translocations involving the USP6 gene in a significant number of ABC cases. Located on chromosome 17, the USP6 gene encodes a ubiquitin-specific protease involved in various cellular processes. The exact oncogenic mechanism by which USP6-related gene fusions contribute to ABC pathogenesis is still being investigated.
Clonal Neoplastic Process: Research has confirmed that both ABCs and their solid variants represent clonal neoplastic processes, indicating a neoplastic origin rather than a purely reactive one. The identification of recurrent genetic abnormalities provides support for the concept of ABCs as genuine neoplasms.
Association with Other Lesions: ABCs may co-occur with other benign bone lesions or syndromes, such as giant cell tumor of bone (GCTB) or fibrous dysplasia. These associations underscore the intricate nature of ABC pathophysiology and suggest potential shared pathways in the development of these lesions.
Etiology
The etiology of aneurysmal bone cysts (ABCs) is multifactorial, with various theories proposed. Lichtenstein (1950) suggested they may result from reactive responses to vascular disturbances or trauma, leading to bone destruction and expansion. Recent studies have identified recurrent chromosomal translocations involving the USP6 gene, confirming ABCs as clonal neoplastic processes. USP6, located on chromosome 17p13.2, regulates cellular processes like protein stability and angiogenesis. Although USP6 rearrangements are associated with ABCs, they’re also found in other benign lesions. Fluorescent in situ hybridization (FISH) and next-generation sequencing (NGS) aid in differentiation. While the exact etiology involves vascular, traumatic, and genetic factors, further research is needed to fully understand ABC pathogenesis.
Genetics
Prognostic Factors
Clinical History
Physical Examination
Physical examination of aneurysmal bone cysts (ABCs) involves:
History and Symptoms: Your doctor will discuss your medical history and inquire about any symptoms related to the affected area.
Physical Assessment: During the examination, your doctor will look for signs such as:
Swelling over the affected bone.
Stiffness in nearby joints.
Deformities or changes in bone shape.
Decreased range of motion.
Presence of pain or tenderness.
Palpable mass or lump.
Imaging Studies: X-rays are typically the initial imaging modality used to evaluate the bone. X-rays can show characteristic changes in bone structure associated with ABCs, such as an enlarged appearance with thinning of the cortex.
Advanced Imaging: If needed, further imaging such as MRI scans may be ordered to provide detailed information about the extent and characteristics of the lesion. MRI scans are particularly useful for visualizing soft tissue involvement and fluid levels within the cyst.
Other Tests: Laboratory tests are generally not diagnostic for ABCs. However, a biopsy may be necessary to confirm the diagnosis. Biopsies can be performed using core needle biopsy or open biopsy techniques, with samples analyzed by a pathologist. Genetic testing for the USP6 gene, associated with many ABCs, can also be conducted as part of the biopsy to aid in diagnosis.
Age group
Associated comorbidity
Associated activity
Acuity of presentation
Differential Diagnoses
Differential diagnoses for aneurysmal bone cysts (ABCs) include:
Giant Cell Tumor of Bone: Another benign bone tumor characterized by the presence of multinucleated giant cells, typically occurring in the epiphyses of long bones.
Osteoblastoma: A benign bone tumor composed of osteoblasts, often presenting with localized pain and swelling.
Chondroblastoma: A rare benign tumor derived from cartilage-producing cells, commonly affecting the epiphyses of long bones.
Fibrous Dysplasia: A benign bone disorder characterized by the replacement of normal bone with fibrous tissue, leading to bone deformities and fractures.
Telangiectatic Osteosarcoma: A malignant bone tumor with cystic spaces filled with blood, which can resemble the radiographic appearance of ABCs.
Laboratory Studies
Imaging Studies
Procedures
Histologic Findings
Staging
Treatment Paradigm
Observation: To follow any changes in size or symptoms, small, asymptomatic aneurysmal bone cysts may be observed over time with routine imaging investigations like X-rays, MRIs, or CT scans. Â
Surgical Intervention:Â
Curettage and bone grafting: Aneurysmal bone cysts are often treated surgically using curettage and bone grafting. In this treatment, a bone incision is made to reach the cystic lesion, and curettes specialized instruments are used to remove the aberrant tissue. Â
Resection: Surgical removal of the afflicted bone segment may be required in some cases where the aneurysmal bone cyst is large or contains vital structures, such as blood vessels or nerves.
Pain Management: One of the most prevalent symptoms of aneurysmal bone cysts is pain. Applying heat or cold therapy to the afflicted area to reduce inflammation and pain.Â
Activity Modification: To stop more harm or damage, specific activity adjustments may be required, depending on the location and size of the aneurysmal bone cyst. Â
Fall Prevention: Aneurysmal bone cysts can raise the risk of fractures or other injuries from falls, especially if they are situated in weight-bearing bones. By clearing living areas of potential trip hazards including loose carpets, cords, and clutter.Â
Role of Analgesics
Acetaminophen: Acetaminophen blocks pain signals in the brain and spinal cord by acting centrally. It is generally well-tolerated and helpful for mild to moderate pain management.Â
Role of NSAID’S
Ibuprofen: It acts by preventing the body from producing prostaglandins, which are substances that increase pain and inflammation. By reducing inflammation and blocking pain signals, ibuprofen can help alleviate pain associated with aneurysmal bone cysts.Â
Percutaneous Sclerotherapy: Percutaneous sclerotherapy involves the injection of a sclerosing agent directly into the cystic cavity of the aneurysmal bone cyst. The goal of sclerotherapy is to induce inflammation and fibrosis within the cyst, leading to its collapse, resolution, and subsequent bone healing.Â
use-of-phases-in-managing-aneurysmal-bone-cyst
Diagnosis: To identify symptoms and indicators that point to aneurysmal bone cysts, a comprehensive clinical evaluation is frequently conducted first.Â
Treatment Modalities: Management options may include observation with periodic imaging, surgical interventions such as curettage with or without bone grafting, percutaneous sclerotherapy, embolization, or in some cases, radiation therapy.Â
Follow-up Monitoring: Patients typically undergo regular follow-up appointments and imaging studies to assess treatment response, monitor for recurrence or complications, and adjust the management plan as needed.Â
Long-term Management: Even after successful treatment, patients with aneurysmal bone cysts may require long-term surveillance to monitor for recurrence or late complications.Â
Aneurysmal bone cysts (ABCs) were identified as a distinct condition in 1942. While their exact cause is unclear, recent studies suggest a potential neoplastic origin involving the USP6 gene. These rare, benign bone tumors typically affect children and adolescents, with the highest occurrence in the second decade of life. Although they can develop in any bone, ABCs are most commonly observed in the long bones of the limbs and the spine. Despite their non-cancerous nature, ABCs can lead to significant health issues due to their locally aggressive behavior, causing pain, swelling, deformity, and fractures. Timely diagnosis and appropriate treatment are essential to manage symptoms and prevent complications.
Aneurysmal bone cysts (ABCs) are rare, benign bone tumors, comprising 1-2% of primary bone tumors. They often affect children and adolescents, with a peak incidence between ages 5 and 20. While occurring in any bone, they preferentially appear in long bone metaphyses, spine, pelvis, and extremities. Clinical presentation includes pain, swelling, and restricted joint movement, with fractures possible. Treatment involves surgical intervention with a recurrence risk of 10-30%, emphasizing the need for comprehensive understanding in diagnosis and management.
The development of aneurysmal bone cysts (ABCs) involves a multifaceted interaction of genetic, molecular, and environmental factors. Although the exact cause remains incompletely understood, various theories have been proposed to explain their mechanisms:
Vascular Disturbances: Initially proposed by Lichtenstein in 1950, this theory suggests that ABCs arise as reactive lesions triggered by regional vascular disruptions. These disturbances result in elevated intraosseous pressure, leading to bone destruction and expansion.
Traumatic Etiology: Another hypothesis implicates trauma as an initial trigger, followed by an abnormal reparative process. Trauma may disrupt the bone’s vascular supply, leading to the formation of a cystic cavity that undergoes subsequent expansion and remodeling.
Genetic Alterations: Recent studies have identified recurrent chromosomal translocations involving the USP6 gene in a significant number of ABC cases. Located on chromosome 17, the USP6 gene encodes a ubiquitin-specific protease involved in various cellular processes. The exact oncogenic mechanism by which USP6-related gene fusions contribute to ABC pathogenesis is still being investigated.
Clonal Neoplastic Process: Research has confirmed that both ABCs and their solid variants represent clonal neoplastic processes, indicating a neoplastic origin rather than a purely reactive one. The identification of recurrent genetic abnormalities provides support for the concept of ABCs as genuine neoplasms.
Association with Other Lesions: ABCs may co-occur with other benign bone lesions or syndromes, such as giant cell tumor of bone (GCTB) or fibrous dysplasia. These associations underscore the intricate nature of ABC pathophysiology and suggest potential shared pathways in the development of these lesions.
The etiology of aneurysmal bone cysts (ABCs) is multifactorial, with various theories proposed. Lichtenstein (1950) suggested they may result from reactive responses to vascular disturbances or trauma, leading to bone destruction and expansion. Recent studies have identified recurrent chromosomal translocations involving the USP6 gene, confirming ABCs as clonal neoplastic processes. USP6, located on chromosome 17p13.2, regulates cellular processes like protein stability and angiogenesis. Although USP6 rearrangements are associated with ABCs, they’re also found in other benign lesions. Fluorescent in situ hybridization (FISH) and next-generation sequencing (NGS) aid in differentiation. While the exact etiology involves vascular, traumatic, and genetic factors, further research is needed to fully understand ABC pathogenesis.
Physical examination of aneurysmal bone cysts (ABCs) involves:
History and Symptoms: Your doctor will discuss your medical history and inquire about any symptoms related to the affected area.
Physical Assessment: During the examination, your doctor will look for signs such as:
Swelling over the affected bone.
Stiffness in nearby joints.
Deformities or changes in bone shape.
Decreased range of motion.
Presence of pain or tenderness.
Palpable mass or lump.
Imaging Studies: X-rays are typically the initial imaging modality used to evaluate the bone. X-rays can show characteristic changes in bone structure associated with ABCs, such as an enlarged appearance with thinning of the cortex.
Advanced Imaging: If needed, further imaging such as MRI scans may be ordered to provide detailed information about the extent and characteristics of the lesion. MRI scans are particularly useful for visualizing soft tissue involvement and fluid levels within the cyst.
Other Tests: Laboratory tests are generally not diagnostic for ABCs. However, a biopsy may be necessary to confirm the diagnosis. Biopsies can be performed using core needle biopsy or open biopsy techniques, with samples analyzed by a pathologist. Genetic testing for the USP6 gene, associated with many ABCs, can also be conducted as part of the biopsy to aid in diagnosis.
Differential diagnoses for aneurysmal bone cysts (ABCs) include:
Giant Cell Tumor of Bone: Another benign bone tumor characterized by the presence of multinucleated giant cells, typically occurring in the epiphyses of long bones.
Osteoblastoma: A benign bone tumor composed of osteoblasts, often presenting with localized pain and swelling.
Chondroblastoma: A rare benign tumor derived from cartilage-producing cells, commonly affecting the epiphyses of long bones.
Fibrous Dysplasia: A benign bone disorder characterized by the replacement of normal bone with fibrous tissue, leading to bone deformities and fractures.
Telangiectatic Osteosarcoma: A malignant bone tumor with cystic spaces filled with blood, which can resemble the radiographic appearance of ABCs.
Observation: To follow any changes in size or symptoms, small, asymptomatic aneurysmal bone cysts may be observed over time with routine imaging investigations like X-rays, MRIs, or CT scans. Â
Surgical Intervention:Â
Curettage and bone grafting: Aneurysmal bone cysts are often treated surgically using curettage and bone grafting. In this treatment, a bone incision is made to reach the cystic lesion, and curettes specialized instruments are used to remove the aberrant tissue. Â
Resection: Surgical removal of the afflicted bone segment may be required in some cases where the aneurysmal bone cyst is large or contains vital structures, such as blood vessels or nerves.
Oncology, Other
Orthopaedic Surgery
Pain Management: One of the most prevalent symptoms of aneurysmal bone cysts is pain. Applying heat or cold therapy to the afflicted area to reduce inflammation and pain.Â
Activity Modification: To stop more harm or damage, specific activity adjustments may be required, depending on the location and size of the aneurysmal bone cyst. Â
Fall Prevention: Aneurysmal bone cysts can raise the risk of fractures or other injuries from falls, especially if they are situated in weight-bearing bones. By clearing living areas of potential trip hazards including loose carpets, cords, and clutter.Â
Orthopaedic Surgery
Pain Management
Acetaminophen: Acetaminophen blocks pain signals in the brain and spinal cord by acting centrally. It is generally well-tolerated and helpful for mild to moderate pain management.Â
Orthopaedic Surgery
Pain Management
Ibuprofen: It acts by preventing the body from producing prostaglandins, which are substances that increase pain and inflammation. By reducing inflammation and blocking pain signals, ibuprofen can help alleviate pain associated with aneurysmal bone cysts.Â
Oncology, Other
Orthopaedic Surgery
Percutaneous Sclerotherapy: Percutaneous sclerotherapy involves the injection of a sclerosing agent directly into the cystic cavity of the aneurysmal bone cyst. The goal of sclerotherapy is to induce inflammation and fibrosis within the cyst, leading to its collapse, resolution, and subsequent bone healing.Â
Orthopaedic Surgery
Diagnosis: To identify symptoms and indicators that point to aneurysmal bone cysts, a comprehensive clinical evaluation is frequently conducted first.Â
Treatment Modalities: Management options may include observation with periodic imaging, surgical interventions such as curettage with or without bone grafting, percutaneous sclerotherapy, embolization, or in some cases, radiation therapy.Â
Follow-up Monitoring: Patients typically undergo regular follow-up appointments and imaging studies to assess treatment response, monitor for recurrence or complications, and adjust the management plan as needed.Â
Long-term Management: Even after successful treatment, patients with aneurysmal bone cysts may require long-term surveillance to monitor for recurrence or late complications.Â
Aneurysmal bone cysts (ABCs) were identified as a distinct condition in 1942. While their exact cause is unclear, recent studies suggest a potential neoplastic origin involving the USP6 gene. These rare, benign bone tumors typically affect children and adolescents, with the highest occurrence in the second decade of life. Although they can develop in any bone, ABCs are most commonly observed in the long bones of the limbs and the spine. Despite their non-cancerous nature, ABCs can lead to significant health issues due to their locally aggressive behavior, causing pain, swelling, deformity, and fractures. Timely diagnosis and appropriate treatment are essential to manage symptoms and prevent complications.
Aneurysmal bone cysts (ABCs) are rare, benign bone tumors, comprising 1-2% of primary bone tumors. They often affect children and adolescents, with a peak incidence between ages 5 and 20. While occurring in any bone, they preferentially appear in long bone metaphyses, spine, pelvis, and extremities. Clinical presentation includes pain, swelling, and restricted joint movement, with fractures possible. Treatment involves surgical intervention with a recurrence risk of 10-30%, emphasizing the need for comprehensive understanding in diagnosis and management.
The development of aneurysmal bone cysts (ABCs) involves a multifaceted interaction of genetic, molecular, and environmental factors. Although the exact cause remains incompletely understood, various theories have been proposed to explain their mechanisms:
Vascular Disturbances: Initially proposed by Lichtenstein in 1950, this theory suggests that ABCs arise as reactive lesions triggered by regional vascular disruptions. These disturbances result in elevated intraosseous pressure, leading to bone destruction and expansion.
Traumatic Etiology: Another hypothesis implicates trauma as an initial trigger, followed by an abnormal reparative process. Trauma may disrupt the bone’s vascular supply, leading to the formation of a cystic cavity that undergoes subsequent expansion and remodeling.
Genetic Alterations: Recent studies have identified recurrent chromosomal translocations involving the USP6 gene in a significant number of ABC cases. Located on chromosome 17, the USP6 gene encodes a ubiquitin-specific protease involved in various cellular processes. The exact oncogenic mechanism by which USP6-related gene fusions contribute to ABC pathogenesis is still being investigated.
Clonal Neoplastic Process: Research has confirmed that both ABCs and their solid variants represent clonal neoplastic processes, indicating a neoplastic origin rather than a purely reactive one. The identification of recurrent genetic abnormalities provides support for the concept of ABCs as genuine neoplasms.
Association with Other Lesions: ABCs may co-occur with other benign bone lesions or syndromes, such as giant cell tumor of bone (GCTB) or fibrous dysplasia. These associations underscore the intricate nature of ABC pathophysiology and suggest potential shared pathways in the development of these lesions.
The etiology of aneurysmal bone cysts (ABCs) is multifactorial, with various theories proposed. Lichtenstein (1950) suggested they may result from reactive responses to vascular disturbances or trauma, leading to bone destruction and expansion. Recent studies have identified recurrent chromosomal translocations involving the USP6 gene, confirming ABCs as clonal neoplastic processes. USP6, located on chromosome 17p13.2, regulates cellular processes like protein stability and angiogenesis. Although USP6 rearrangements are associated with ABCs, they’re also found in other benign lesions. Fluorescent in situ hybridization (FISH) and next-generation sequencing (NGS) aid in differentiation. While the exact etiology involves vascular, traumatic, and genetic factors, further research is needed to fully understand ABC pathogenesis.
Physical examination of aneurysmal bone cysts (ABCs) involves:
History and Symptoms: Your doctor will discuss your medical history and inquire about any symptoms related to the affected area.
Physical Assessment: During the examination, your doctor will look for signs such as:
Swelling over the affected bone.
Stiffness in nearby joints.
Deformities or changes in bone shape.
Decreased range of motion.
Presence of pain or tenderness.
Palpable mass or lump.
Imaging Studies: X-rays are typically the initial imaging modality used to evaluate the bone. X-rays can show characteristic changes in bone structure associated with ABCs, such as an enlarged appearance with thinning of the cortex.
Advanced Imaging: If needed, further imaging such as MRI scans may be ordered to provide detailed information about the extent and characteristics of the lesion. MRI scans are particularly useful for visualizing soft tissue involvement and fluid levels within the cyst.
Other Tests: Laboratory tests are generally not diagnostic for ABCs. However, a biopsy may be necessary to confirm the diagnosis. Biopsies can be performed using core needle biopsy or open biopsy techniques, with samples analyzed by a pathologist. Genetic testing for the USP6 gene, associated with many ABCs, can also be conducted as part of the biopsy to aid in diagnosis.
Differential diagnoses for aneurysmal bone cysts (ABCs) include:
Giant Cell Tumor of Bone: Another benign bone tumor characterized by the presence of multinucleated giant cells, typically occurring in the epiphyses of long bones.
Osteoblastoma: A benign bone tumor composed of osteoblasts, often presenting with localized pain and swelling.
Chondroblastoma: A rare benign tumor derived from cartilage-producing cells, commonly affecting the epiphyses of long bones.
Fibrous Dysplasia: A benign bone disorder characterized by the replacement of normal bone with fibrous tissue, leading to bone deformities and fractures.
Telangiectatic Osteosarcoma: A malignant bone tumor with cystic spaces filled with blood, which can resemble the radiographic appearance of ABCs.
Observation: To follow any changes in size or symptoms, small, asymptomatic aneurysmal bone cysts may be observed over time with routine imaging investigations like X-rays, MRIs, or CT scans. Â
Surgical Intervention:Â
Curettage and bone grafting: Aneurysmal bone cysts are often treated surgically using curettage and bone grafting. In this treatment, a bone incision is made to reach the cystic lesion, and curettes specialized instruments are used to remove the aberrant tissue. Â
Resection: Surgical removal of the afflicted bone segment may be required in some cases where the aneurysmal bone cyst is large or contains vital structures, such as blood vessels or nerves.
Oncology, Other
Orthopaedic Surgery
Pain Management: One of the most prevalent symptoms of aneurysmal bone cysts is pain. Applying heat or cold therapy to the afflicted area to reduce inflammation and pain.Â
Activity Modification: To stop more harm or damage, specific activity adjustments may be required, depending on the location and size of the aneurysmal bone cyst. Â
Fall Prevention: Aneurysmal bone cysts can raise the risk of fractures or other injuries from falls, especially if they are situated in weight-bearing bones. By clearing living areas of potential trip hazards including loose carpets, cords, and clutter.Â
Orthopaedic Surgery
Pain Management
Acetaminophen: Acetaminophen blocks pain signals in the brain and spinal cord by acting centrally. It is generally well-tolerated and helpful for mild to moderate pain management.Â
Orthopaedic Surgery
Pain Management
Ibuprofen: It acts by preventing the body from producing prostaglandins, which are substances that increase pain and inflammation. By reducing inflammation and blocking pain signals, ibuprofen can help alleviate pain associated with aneurysmal bone cysts.Â
Oncology, Other
Orthopaedic Surgery
Percutaneous Sclerotherapy: Percutaneous sclerotherapy involves the injection of a sclerosing agent directly into the cystic cavity of the aneurysmal bone cyst. The goal of sclerotherapy is to induce inflammation and fibrosis within the cyst, leading to its collapse, resolution, and subsequent bone healing.Â
Orthopaedic Surgery
Diagnosis: To identify symptoms and indicators that point to aneurysmal bone cysts, a comprehensive clinical evaluation is frequently conducted first.Â
Treatment Modalities: Management options may include observation with periodic imaging, surgical interventions such as curettage with or without bone grafting, percutaneous sclerotherapy, embolization, or in some cases, radiation therapy.Â
Follow-up Monitoring: Patients typically undergo regular follow-up appointments and imaging studies to assess treatment response, monitor for recurrence or complications, and adjust the management plan as needed.Â
Long-term Management: Even after successful treatment, patients with aneurysmal bone cysts may require long-term surveillance to monitor for recurrence or late complications.Â
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Digital Certificate PDF
On course completion, you will receive a full-sized presentation quality digital certificate.
medtigo Simulation
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
medtigo Points
medtigo points is our unique point redemption system created to award users for interacting on our site. These points can be redeemed for special discounts on the medtigo marketplace as well as towards the membership cost itself.
Community Forum post/reply = 5 points
*Redemption of points can occur only through the medtigo marketplace, courses, or simulation system. Money will not be credited to your bank account. 10 points = $1.
All Your Certificates in One Place
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
